
The stock market is up slightly in response to election results, but drug company investors are freaking out. The simple, semi-paranoid explanation is that Dems are more likely to force lower drug prices with soft price caps, demands for cheap generics, and permission for more importation from Canada. This means lower profits in the short term, less R&D in the long term.
Stolen, intact, from Greg Mankiw.
Reason on Facebook
Reason on Twitter
Reason on YouTube
Reason RSS
Site comments/questions:
Media Inquiries and Reprint Permissions:
(310) 367-6109
Editorial & Production Offices:
3415 S. Sepulveda Blvd.
Suite 400
Los Angeles, CA 90034
(310) 391-2245